EP Lab

This channel includes news and new technology innovations for cardiac electrophysiology (EP) systems, techniques and devices using in EP labs. This includes implantable EP devices, pacemakers, implantable cardioverter defibrillators (ICD), cardiac resychronization therapy (CRT), ablation technologies, left atrial appendage (LAA) occlusion, atrial fibrilation (AF) and Holter monitors.

Medical center signs agreement to acquire the Company’s digital signal processing technology for arrhythmia care
News | EP Device Monitoring Systems
BioSig Executes Agreement with Bellin Health for the Acquisition of its PURE EP Technology

January 13, 2023 — BioSig Technologies, Inc., an advanced digital signal processing technology company delivering ...

Home January 13, 2023
Home
While playing in the Buffalo Bills - Cincinnati Bengals game on Monday Night Football on January 2, Bills player Damar Hamlin suffered cardiac arrest after a hit and was administered CPR on the field before being transferred to an area hospital, according to an overnight statement by the Buffalo Bills
News | Sudden Cardiac Arrest
AHA Issues Statement on Understanding Cardiac Arrest Following Damar Hamlin's Collapse During Monday Night Football

January 4, 2023 — While playing in the Buffalo Bills - Cincinnati Bengals game on Monday Night Football on January 2 ...

Home January 04, 2023
Home
A heart-pacing lead is a small catheter with electrodes.
News | Leads Implantable Devices
Cardiac Pacing Leads Market Will Reach $394 million by 2029

January 3, 2023 — The market has been studied for the below mentioned-segmentation and regional analysis for North ...

Home January 03, 2023
Home
Acutus Medical, Inc., an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, announced the acceptance of the AcQForce Flutter abstract titled “AcQForce Flutter Trial Clinical Results: Force Sensing RF Ablation with Low Flow Gold Tip Catheter for Typical Flutter”
News | Cardiovascular Clinical Studies
Acutus Medical Announces Acceptance of the AcQForce Flutter Abstract for Presentation at the 2023 AF Symposium

January 3, 2023 — Acutus Medical, Inc., an arrhythmia management company focused on improving the way cardiac ...

Home January 03, 2023
Home
The Arrhythmia Care Team at Corewell Health Celebrate First Successful Procedures With New Genesis Robotic Cardiac Ablation System from Stereotaxis.
News
Corewell Health Grows Robotic Program to Treat Heart Rhythm Disorders with Adoption of Stereotaxis’ Genesis System

December 21, 2022 — Stereotaxis, a global leader in robotic technologies for the treatment of cardiac arrhythmias ...

Home December 21, 2022
Home
Verseon’s scientific journey to highly promising therapeutic candidates for cardiovascular disease appears in European Journal of Medicinal Chemistry
News | Atrial Fibrillation
Field Medical and CardioNXT Collaborate to Deliver Novel Integration of Focal Pulsed Field Ablation And 3D Mapping & Navigation For Treatment of Cardiac Arrhythmias

December 14, 2022 —  Field Medical, Inc. and CardioNXT, Inc. announce a strategic collaboration to provide the first-of ...

Home December 14, 2022
Home
The global pacemakers market is set to grow at a compound annual growth rate (CAGR) of 5.4% between 2022 and 2025, driven by increasing population at a risk of cardiovascular diseases.
News | Pacemakers
Global Pacemakers Market Set to Grow at 5.4% CAGR Over Next 3 Years

December 12, 2022 —  The global pacemakers market is set to grow at a compound annual growth rate (CAGR) of 5.4% between ...

Home December 12, 2022
Home
Clinical abstract focuses on value of PURE EP’s and its groundbreaking High Frequency Algorithm (HFA) during pulmonary vein isolation
News | Cardiovascular Clinical Studies
BioSig’s PURE EP System Highlighted in the Journal of Atrial Fibrillation and Electrophysiology

December 9, 2022 —    BioSig Technologies, Inc.  an advanced digital signal processing technology company delivering ...

Home December 09, 2022
Home
CroíValve has announced the successful First in Human implants of its DUO Tricuspid Coaptation Valve technology for the treatment of Tricuspid Regurgitation as part of its TANDEM I study in Poland.
News | Heart Valve Technology
CroíValve Reports Successful First in Human Implants of its DUO Tricuspid Coaptation Valve System

November 22, 2022 — CroíValve has announced the successful First in Human implants of its DUO Tricuspid Coaptation Valve ...

Home November 22, 2022
Home
Investigators Compared AFib Patients Treated with Catheter Ablation to Those Treated with Anti-arrhythmic Drugs Only
News | Atrial Fibrillation
Study Finds Catheter Ablation Significantly Lowers Risk of Dementia in Patients with Atrial Fibrillation

November 10, 2022 —  Biosense Webster, Inc., the global leader in cardiac arrhythmia treatment and part of Johnson & ...

Home November 10, 2022
Home
Cryoablation involves guiding a small tube into the heart and inflating a small balloon to kill problematic tissue with cold temperatures. Image courtesy of Medtronic
News | Atrial Fibrillation
National Study Suggests It's Time to Rethink How We Treat Atrial Fibrillation

November 10, 2022 —  A national study led by UBC researchers at the Centre for Cardiovascular Innovation is shedding ...

Home November 10, 2022
Home
Clinical studies presented at the American Heart Association 2022 Scientific Sessions event demonstrate compelling diagnostic and health economic value of the Zio suite of products across a range of clinical applications
News | AHA
Results of Four Studies Demonstrating Clinical, Economic Value of iRhythm’s Product Portfolio Presented at American Heart Association ’22

November 8, 2022 — iRhythm Technologies, Inc., a leading cardiovascular diagnostics and digital healthcare solutions ...

Home November 08, 2022
Home
A new analysis of iRhythm’s mSToPS trial, presented at the American Heart Association, reveals that Zio XT provided high value from a health economic perspective
News | AHA
New Research Confirms that Zio by iRhythm Provides High Value From a Health Economic Perspective

November 7, 2022 — iRhythm Technologies, Inc., a leading cardiovascular diagnostics and digital healthcare solutions ...

Home November 07, 2022
Home
Study Advances Efforts to Launch CARDIALYTICS Suite of Analytic Tools
News | EP Lab
CathVision Announces Initiation of Clinical Study Evaluating Signal Complexity Algorithm

Nov. 4, 2022 — CathVision, a medical technology company developing innovative electrophysiology solutions to enhance ...

Home November 05, 2022
Home
About one-fifth of implants of left ventricular-assist devices have the complication of right heart failure. Abbott Laboratories (adapted)
News | Ventricular Assist Devices (VAD)
Study Sifts Potential Factors of Device-Implant Complication

November 2, 2022 — For decades, left ventricular-assist devices (LVADs) have extended the lives of people whose hearts ...

Home November 02, 2022
Home
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now